Insights / Awards
Clinion Shines at SCDM 2024 with Award-Winning AI Innovations
Clinion is proud to be recognized with the SCDM Innovation Award for Clinical Data Science Implementation Excellence at the SCDM Annual Conference 2024 in Boston. This global recognition highlights our dedication to advancing clinical trial management and redefining standards in clinical data science.
Why Clinion Stands Out
Clinion’s eClinical solutions seamlessly integrate AI and automation to enhance trial efficiency and accuracy. Some key features that set it apart are:
CDASH Annotation with AI
Clinion’s AI-driven CDASH Annotation simplifies the traditionally manual task of creating annotated Case Report Forms (CRFs). By automating the mapping of study data to CDASH standards, our AI reduces human error, ensures compliance, and shortens study setup time by up to 30%.
Gen AI-Powered Data Review: Empowering Data Managers
Clinion’s revolutionary Gen AI-powered data review tool empowers data managers to instantly generate datasets and raise queries, eliminating the dependency on biostatisticians. Using simple English prompts, data managers can create any kind of dataset and then review and raise queries directly from the datasets. This self-serve capability not only improves data quality but also saves time and reduces manual effort.
Dynamic Reporting with Gen AI: Real-Time Insights
Traditional reporting methods are often slow and complex, hindering timely decision-making. Clinion EDC’s Gen AI technology solves this by enabling data managers to instantly generate custom reports and visualizations. These reports can be saved, scheduled for regular intervals, and shared with stakeholders in real time, enabling faster, more data-driven decision-making.
The Clinion Advantage
Faster study setup
Faster data review
Faster report generation
CEO’s Quote
“We are honored to receive the SCDM Innovation Award. It reflects our commitment to pushing the boundaries of clinical data management through advanced AI and automation. Our mission has always been to simplify complex trial processes while ensuring unmatched data accuracy and operational efficiency. This award validates our efforts and inspires us to continue delivering solutions that revolutionize the industry.”- Manuj Vangipurapu, Founder & CEO of Clinion
Why This Award Matters
This recognition reinforces our commitment to leveraging AI and GenAI to simplify trial processes, achieve superior data accuracy, and deliver faster, more reliable outcomes. It validates our continuous innovation and reflects our mission to enhance efficiency, reduce timelines, and drive measurable value for our partners.
Unlock the Future of Clinical Trials with Clinion.
Cut your trial costs by 35% and accelerate your time-to-market by 30%
Compliance
Fully Compliant with Global Standards
